Issue 24, 2002
From the journal:

Chemical Communications

Versatile enantiocontrolled synthesis of (+)-fostriecin†

Tomoyuki Esumi,a   Nanako Okamotoa  and  Susumi Hatakeyama*a  

* Corresponding authors

a Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
E-mail: susumi@net.nagasaki-u.ac.jp

Abstract

Fostriecin, a potent protein phosphatase inhibitor and antitumor agent, has been enantioselectively synthesized in naturally occurring form via a versatile route, which also allows one to secure all possible stereoisomeres of the C1–C13 fragment including the C11 stereocenter and the geometry of the Δ12-double bond.

Graphical abstract: Versatile enantiocontrolled synthesis of (+)-fostriecin

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/B209742G
Article type
Communication
Submitted
07 Oct 2002
Accepted
29 Oct 2002
First published
15 Nov 2002

Chem. Commun., 2002, 3042-3043

Permissions

Request permissions

Versatile enantiocontrolled synthesis of (+)-fostriecin

T. Esumi, N. Okamoto and S. Hatakeyama, Chem. Commun., 2002, 3042 DOI: 10.1039/B209742G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements